Evaluating the effectiveness of telehealth for buprenorphine treatment in opioid use disorder
Evaluating real-world effectiveness of tele-buprenorphine: A mixed-methods study to develop clinical guidance
This study is looking at how well telehealth treatment with buprenorphine works for people with opioid use disorder, especially for those who might have a harder time getting help, and it wants to hear from patients about their experiences to improve care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11163301 on NIH RePORTER |
What this research studies
This research investigates how effective telehealth-delivered buprenorphine treatment is for individuals with opioid use disorder (OUD). It aims to gather real-world data on the effectiveness of this treatment, especially for high-risk groups and those facing treatment disparities. By using innovative methods to analyze existing data, the study seeks to provide clinical guidance on the best ways to implement tele-buprenorphine in various healthcare settings. Patients may be involved in discussions about their treatment experiences and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with opioid use disorder, especially those who may benefit from telehealth services.
Not a fit: Patients who are not experiencing opioid use disorder or those who do not have access to telehealth services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve access to effective treatment for opioid use disorder, particularly for underserved populations.
How similar studies have performed: While telehealth for substance use treatment is a growing field, this specific approach to evaluating tele-buprenorphine effectiveness is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Lin, Lewei Allison — University of Michigan at Ann Arbor
- Study coordinator: Lin, Lewei Allison
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.